Cargando…
Anti-cancer Therapies in High Grade Gliomas
High grade gliomas represent one of the most aggressive and treatment-resistant types of human cancer, with only 1–2 years median survival rate for patients with grade IV glioma. The treatment of glioblastoma is a considerable therapeutic challenge; combination therapy targeting multiple pathways is...
Autores principales: | Tanase, Cristiana Pistol, Enciu, Ana-Maria, Mihai, Simona, Neagu, Ana Iulia, Calenic, Bogdan, Cruceru, Maria Linda |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3821381/ https://www.ncbi.nlm.nih.gov/pubmed/24228024 http://dx.doi.org/10.2174/1570164611310030007 |
Ejemplares similares
-
Signal transduction molecule patterns indicating potential glioblastoma therapy approaches
por: Cruceru, Maria Linda, et al.
Publicado: (2013) -
Decreased expression of APAF-1 and increased expression of cathepsin B in invasive pituitary adenoma
por: Tanase, Cristiana, et al.
Publicado: (2014) -
Glioma Stem Cells and Their Microenvironments: Providers of Challenging Therapeutic Targets
por: Codrici, Elena, et al.
Publicado: (2016) -
Potential serum biomarkers for glioblastoma diagnostic assessed by proteomic approaches
por: Popescu, Ionela Daniela, et al.
Publicado: (2014) -
Long non‐coding RNAs in brain tumours: Focus on recent epigenetic findings in glioma
por: Pop, Sevinci, et al.
Publicado: (2018)